Holen Sie sich die Stockscreener-App
1.75
11.82%
0.185
Vorhandelsmarkt:
1.42
-0.33
-18.86%
Schlusskurs vom Vortag:
$1.565
Offen:
$1.69
24-Stunden-Volumen:
45.75M
Relative Volume:
54.44
Marktkapitalisierung:
$40.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+29.63%
1M Leistung:
+47.06%
6M Leistung:
-3.85%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.57
$2.18
1-Wochen-Bereich:
$1.30
$2.18
52-Wochen-Spanne:
$1.04
$3.50
Rein Therapeutics Inc Stock (RNTX) Company Profile
Firmenname
Rein Therapeutics Inc
Sektor
Branche
Telefon
(737) 802-1989
Adresse
12407 N. MOPAC EXPY., AUSTIN
Vergleichen Sie RNTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNTX
Rein Therapeutics Inc
|
1.75 | 37.60M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rein Therapeutics Inc Stock (RNTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2017-07-24 | Eingeleitet | BofA/Merrill | Buy |
| 2017-07-24 | Eingeleitet | Jefferies | Buy |
| 2017-07-24 | Eingeleitet | William Blair | Outperform |
Rein Therapeutics Inc Aktie (RNTX) Neueste Nachrichten
How Rein Therapeutics Inc. stock reacts to bond yieldsJuly 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
Comparing Rein Therapeutics Inc. in custom built stock radars2025 Market Trends & Fast Entry High Yield Stock Tips - newser.com
Will Rein Therapeutics Inc. stock maintain momentum in 20252025 Price Momentum & Weekly Hot Stock Watchlists - newser.com
Ranking Rein Therapeutics Inc. among high performing stocks via toolsSell Signal & AI Enhanced Trading Signals - newser.com
Price momentum metrics for Rein Therapeutics Inc. explained2025 Institutional Moves & Long Hold Capital Preservation Plans - newser.com
Rein Therapeutics Inc. (RNTX) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis - MarketScreener
Brookline Capital Markets upgrades Rein Therapeutics stock rating to Buy By Investing.com - Investing.com Canada
RNTX Jolted: Analyzing Stock Movement - StocksToTrade
Why Is Rein Therapeutics Stock Trading Higher On Monday? - Benzinga
Technical signs of recovery in Rein Therapeutics Inc.July 2025 Technicals & Free Long-Term Investment Growth Plans - newser.com
Rein Therapeutics Receives FDA Clearance to Resume Phase 2 Trial - TradingView
News impact scoring models applied to Rein Therapeutics Inc.Weekly Profit Analysis & AI Optimized Trading Strategy Guides - newser.com
Using economic indicators to assess Rein Therapeutics Inc. potentialWeekly Stock Report & Safe Swing Trade Setups - newser.com
Multi asset correlation models including Rein Therapeutics Inc.Weekly Trend Summary & Daily Growth Stock Tips - newser.com
Why Rein Therapeutics Inc. stock attracts high net worth investorsTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com
Will Rein Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Update & Short-Term Trading Opportunity Alerts - newser.com
Why retail investors pile into Rein Therapeutics Inc. stock2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com
Rein Therapeutics Inc. stock retracement – recovery analysis2025 Geopolitical Influence & AI Driven Price Predictions - newser.com
Rein Therapeutics Inc. Stock (RNTX) Opinions on Institutional Investments and Funding Deals - Quiver Quantitative
Is Rein Therapeutics Inc. stock a defensive play in 20252025 Market WrapUp & AI Based Trade Execution Alerts - fcp.pa.gov.br
How rising interest rates impact Rein Therapeutics Inc. stock2025 Growth vs Value & AI Driven Stock Reports - fcp.pa.gov.br
Finanzdaten der Rein Therapeutics Inc-Aktie (RNTX)
Es liegen keine Finanzdaten für Rein Therapeutics Inc (RNTX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Rein Therapeutics Inc-Aktie (RNTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Voss Capital, LP | 10% Owner |
Oct 27 '25 |
Buy |
1.37 |
97,482 |
133,544 |
822,258 |
| Voss Capital, LP | 10% Owner |
Oct 24 '25 |
Buy |
1.39 |
30,176 |
41,957 |
729,616 |
| WINDSOR JAMES BRIAN | President and CEO |
Dec 05 '24 |
Buy |
2.24 |
400 |
898 |
239 |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):